BVAXF

PINK BioVaxys Technology Corp
Oct 3, 2026 · 6:57 PM ET EOD Market Closed

$0.1300 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1300, and at the day’s high of $0.1300

YTD change
-23.21%
vs 20-day SMA
+43.61%
vs 200-day SMA
+13.03%

Price ranges

Previous day
$0.0685 $0.1300
open $0.0721 close $0.1300
+$0.0580 (+80.43%)
Today
$0.0685 $0.1300
$0.1300
Past week
$0.0102 $0.0978
from $0.0978 now $0.1300
+$0.0322 (+32.92%)
Past month
$0.0102 $0.1392
from $0.0698 now $0.1300
+$0.0602 (+86.25%)
This year
$0.0102 $0.1900
from $0.1693 now $0.1300
-$0.0393 (-23.21%)

Price & Performance

+0.07 (+135.08%) / 6M

$0.0206$0.0773$0.1340$0.1907Apr 6Jul 1Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 41.2% away from all-time highs of $0.2210
  • BVAXF is down 23% since the beginning of the year
  • BVAXF is down 40% over the past 12 months
  • BVAXF is up 86% over the past 1 month
  • 0% of all BVAXF investors are betting against BVAXF

BVAXF reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -39.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0227
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.5M
Beta 5.92

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$3.0K
Debt$97.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $5.7M

BioVaxys Technology Corp. is a clinical stage biotechnology company. It engages in developing viral and oncology vaccine platforms, as well as immuno-diagnostics. The firm is advancing a SARS-CoV-2 vaccine based on its haptenized viral protein technology and is preparing for a clinical trial of its haptenized autologous cell vaccine used in combination with anti-PD1 and anti-PDL-1 checkpoint inhibitors that will initially be developed for Stage III/Stage IV ovarian cancer. The company was founded by James Christopher Passin, Kenneth E. Kovan and David Berd on April 25, 2018 and is headquartered in Etobicoke, Canada.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.